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Edited by S. KhorasanizadehIn this issue of the Journal of Molecular Biology,
Schumacher et al. investigate the molecular mech-
anisms underlying the ability of the members of
Class II ubiquitin-conjugating enzymes (E2s) to
catalyze the formation of polyubiquitin chains [1]. In
addition to the highly conserved catalytic domain
(the core ubiquitin-conjugating domain, UBC, of
~150 residues), the human UBE2E proteins studied
here contain N-terminal intrinsically disordered (ID)
extensions of different lengths [2]. The authors
suggest that these extended extensions are a key
for extending the E2 functionality. The impact of this
important observation goes far beyond the under-
standing of how the ubiquitination machinery acts,
since (a) it argues that studying the intact proteins,
not just their core catalytic domains, is important for
complete understanding of protein functionality, and
(b) it provides new clues on how the protein
functionality can be controlled and modulated via
non-catalytic and therefore seemingly useless
extended extensions, ID regions. A brief descrip-
tion of what is extended (i.e., a short description of
the protein intrinsic disorder phenomenon with the
focus on disordered tails) from what (i.e., an
overview of the ubiquitination machinery with the
focus on UBE2E proteins) is given below to help
better appreciate the importance of these
conclusions.
The last decade and a half witnessed an increased
recognition that a biologically active protein is not
obligated to possess a unique three-dimensional
structure as a whole or in part and that many
biologically important functions may originate from
the lack of ordered structure in a protein molecule [3–
6], and these functions are complementary to the
functions of ordered proteins [3,7–9]. Such structure-
less functional proteins andprotein domainsare knownthor. Published by Elsevier Ltd. Open access unas ID proteins (IDPs) and hybrid proteins possessing
ordered domains and IDP regions (IDPRs) [10]. IDPs/
IDPRs are very common in nature [11], possess wide
structural heterogeneity [12], and are abundantly
involved in various biological processes, where they
play crucial rolesby regulating functionsof their carriers
(IDPRs) or binding partners (IDPs and IDPRs) [3–9].
Importantly, intrinsic disorder is unevenly distributed
within the hybrid proteins, being typically more
common at protein termini [13]. Many biological
functions are unique for disordered termini and cannot
be found in other disordered parts of a protein,
suggesting that these disordered tails are not simple
flexible protrusions but are evolved to serve [13].
Ubiquitination is an intriguing and unique post-
translational modification (PTM) of proteins. This
intriguing nature and uniqueness of ubiquitination are
obvious at several levels. First, this PTM represents a
covalent attachment of ubiquitin or one of the ubiquitin-
like proteins [Ubls, such as small ubiquitin-like modifier
(SUMO), interferon-induced 15-kDa protein (ISG15),
or neural precursor cell expressed developmentally
down-regulated protein 8 (NEDD8)] [14] to a target
protein, whereas the vast majority of other PTMs are
based on the covalent attachments of relatively small
chemical groups. Therefore, the ubiquitin or Ubl protein
attachment provides a large interaction surface by
which the modification can be decoded [15,16].
Second, ubiquitination is known to be delivered in
several flavors, and one target protein can be mono-,
multi-, and polyubiquitinated, depending on the
number and mutual configuration of attached ubiqui-
tin molecules [17–19]. Here, the multiubiquitination
is a result of multiple lysine residues of one target
protein being used for the ubiquitin attachment
[17,19], whereas polyubiquitination can be produced
when the lysines of the substrate-conjugatedJ. Mol. Biol. (2013) 425, 4067–4070der CC BY license.
4068 The UBE2E Proteins as Conjugating Dispersersubiquitin(s) are used as subsequent ubiquitin attach-
ment points [18,19]. The complexity of this PTM and
its outputs is further increased by the fact that
polyubiquitin chains can be “linear” (no more than
one amino group of each ubiquitin is linked to
another ubiquitin) or “branched/forked” (at least one
ubiquitin is attached to other ubiquitins via two or
more different amino groups) [16,20]. Also, the
polyubiquitin chains can also be mixed and contain
other heterologous proteins from the ubiquitin family
such as SUMO [16,21].
Third, due to the large interaction surface and
added complexity due to the ability to be delivered in
mono-, multi-, and polyubiquitinated forms, this PTM
is not only crucial for the control of almost all cellular
processes by mediating the regulated degradation of
proteins, but it often defines the fate of a modified
protein affecting transcriptional regulation, traffick-
ing, endocytosis, lysosomal targeting, and other
types of targeting/localization, protein–protein inter-
action, complex assembly, modulation of function or
stability, and so on [18]. Furthermore, multiubiquiti-
nation and polyubiquitination can generate diverse
substrate–ubiquitin structures, defining different
fates of target proteins [22,23]. For example, DNA
repair and gene expression are regulated by mono-
ubiquitination, whereas K48 proteins are typically
targeted for proteasomal degradation, while K63
polyubiquitination is needed for regulation of kinase
activation, DNA damage tolerance, signal transduc-
tion, and endocytosis [22].
Fourth, in contrast to many other PTMs, where the
modifying group is added to the target protein by one
enzyme, ubiquitination (which is the attachment of
ubiquitin or Ubl protein to lysine residues on a target
protein via the formation of the isopeptide bond
between the C-terminus of ubiquitin and an amine
from the lysine of the substrate protein) requires a
complex cascade of catalytic reactions that involves
three classes of enzyme, an E1 ubiquitin-activating
enzyme (also known as Uba1), an E2 ubiquitin-con-
jugating enzyme (also known as Ubc), and an E3
ubiquitin ligase [18].
Finally, fifth, the complexity of this PTM is further
increased by the fact that the ubiquitinome (i.e., a set
of protein involved in the ubiquitination or the
ubiquitin pathway) is large and intriguingly inter-
twined. For example, human genome contains
several Uba1 or E1 enzymes, more than 50 Ubcs
or E2s, and several hundred E3s [24]. E2s are
recognized as key players of the ubiquitin pathway,
since they control the fate of the target proteins by
modulating processivity and topology of the poly-
ubiquitin chain assembly [25]. Furthermore, although
many E2s synthesize multiple types of linkages, an
interplay between the various E2s and E3s not only
is crucial for targeting specific proteins for ubiquitina-
tion but also defines the length and linkage type of
polyubiquitin chains, and in most cases, the E3ligase is required for assembly of a polyubiquitin
chain on a protein acceptor [16].
E2s are grouped into four structural classes
depending on the presence/absence and the local-
ization of the non-catalytic extensions relative to the
UBC domain [2]. Class I includes UBC-only E2s,
classes II and III consist of E2s possessing the
catalytic domain and additional N- or C-terminal
extensions, respectively, whereas E2s having both
N- or C-terminal extensions belong to class IV. In
human ubiquitinome, there are at least 14, 9, 9, and
3 E2s in classes I, II, II, and IV, respectively [2].
Earlier bioinformatics and computational analyses
revealed that the C-terminal acidic domains of the
class III E2s possess all the features typical of the
extended IDPs/IDPRs, with high mean net charge
and low mean hydropathy being the most obvious
characteristics [25]. Furthermore, this study empha-
sized that the acidic ID domain of the class III E2s,
which is involved in recognition of ubiquitin and/or E3
ligase, is functionally important [25].
The work by Schumacher et al. continues to shed
light on the role of intrinsic disorder in the function of
the ubiquitination machinery [1]. Using a set of
experimental and computational tools, the authors
showed that the human members of the class II E2s,
UBE2E1, UBE2E2, and UBE2E3, contain ID N-ter-
minal tails. This is illustrated in Fig. 1, which shows
available crystal structures for human UBE2E1 and
UBE2E2 (Fig. 1a and b, respectively) and predicted
disorder propensities of UBE2E1, UBE2E2, and
UBE2E3 (Fig. 1c). Due to the high propensity for
intrinsic disorder, the N-terminal extension either is
mostly absent from the protein structure [as shown in
Fig. 1a, where only 7 of 41 N-terminal residues are
detected as a short structured region (residues 21–
27)] or was deleted from a prior protein crystallization
(as shown in Fig. 1b). Figure 1c shows that the UBC
domains of UBE2E1, UBE2E2, and UBE2E3 are
predicted to be ordered and conserved and also
shows that the N-terminal extensions of these three
E2s are all predicted to be mostly disordered.
Although this is an interesting observation, the
even more intriguing twist is how this disordered tail
is used by UBE2Es. The authors show that the UBC
domains of E2s, being present alone, are responsi-
ble for the polyubiquitination of target proteins,
whereas this polyubiquitinated capability is limited
when the UBC domains are decorated with the
disordered N-terminal tails, since the full-length
UBE2E proteins primarily promote protein mono-
ubiquitylation. Therefore, the highly flexible nature of
the disordered N-terminal extensions is used by
UBE2Es to limit the processivity of their catalytic
domains. In other words, the disordered tail prevents
polyubiquitin chain building by somehow restricting
the donor ubiquitin molecule from accessing the
acceptor ubiquitin at the E2 active site. Although the
nature of this interaction is uncertain, it is possible
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Fig. 1. Order and disorder in human UBE2E proteins. (a) Crystal structure of human UBE2E1 [Protein Data Bank (PDB) ID:
3BZH]. Although the full-length protein was used in the crystallization experiments, the N-terminal domain (residues 1–41) is
mostly unresolved. In fact, residues 1–20 and 28–41 are expected to be disordered since they are located in regions of missing
electron density. (b)Crystal structure of humanUBE2E2 (PDB ID: 1Y6L).N-terminally truncatedproteinwith removedN-terminal
residues 1–53was used crystallized. (c) PONDR-FIT plot representing disorder propensities in humanUBE2E1 (red continuous
line and pink shade), UBE2E2 (blue broken line and cyan shade), and UBE2E3 (orange dot/dash line and yellow shade). In this
plot, lines represent per-residue disorder scores and shades show distribution of errors in evaluation of PONDR-FIT scores.
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4070 The UBE2E Proteins as Conjugating Dispersersthat the N-terminal IDPRs of UBE2E proteins act as
entropic bristles, that is, highly flexible protein
protrusions, which, being involved in constant
random movements, sweep out a significant region
in space and entropically exclude large particles
without excluding small molecules [26,27]. One
major point here is that if this hypothesis is correct,
then adding any disordered sequence instead of a
natural tail will have a similar effect on theUBE2E action
and the building of the polyubiquitin chain will be limited.References
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